◼ Archived
Business
New Type of Blood Thinner Approved to Prevent Repeat Strokes
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.
3 trends tracked about this subject — the full history, oldest to newest below.
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.
Roivant Sciences stock surges as its experimental inhaled lung disease drug hits mid-stage study goals.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.